# GlobeStar Therapeutics Corporation (GSTC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/GSTC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -564.4K | $ -79.4K | $ 329.0K | $ -1.62M |
| 2023 | $ 0 | $ -2.11M | $ -222.5K | $ 366.0K | $ -1.43M |
| 2022 | $ 0 | $ -1.66M | $ -365.3K | N/A | $ -1.19M |
| 2021 | $ 5.7K | $ -11.65M | $ -893.0K | $ 106.1K | $ -725.8K |
| 2020 | $ 98 | $ -690.1K | $ -305.4K | $ 155.1K | $ -659.2K |
| 2019 | $ 549 | $ -871.3K | $ -335.8K | $ 113.8K | $ -685.4K |
| 2018 | $ 1.2K | $ -1.08M | $ -237.8K | $ 285.3K | $ -870.7K |
| 2017 | $ 0 | $ -2.26M | $ -103.3K | $ 88.8K | $ -624.0K |
| 2016 | $ 22.0K | $ -690.9K | $ -193.7K | $ 424.5K | $ 2.54M |
| 2015 | $ 59.2K | $ -1.52M | $ -585.1K | $ 110.3K | $ 12.6K |
| 2014 | $ 137.4K | $ -1.76M | $ -587.6K | $ 256.6K | $ -104.4K |
| 2013 | $ 81.6K | $ -1.35M | $ -842.8K | $ 76.3K | $ 245.3K |
| 2012 | $ -405.4K | $ -1.57M | $ -411.5K | $ 329.1K | $ -106.1K |
| 2011 | $ 0 | $ -79.5K | $ -77.1K | $ 28.0K | $ -9.7K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.20 |
| Liabilities / Eq | -1.05 |
| Current Ratio | 0.05 |

## Other views

- [Metrics](https://sponda.capital/en/GSTC.md)
- [Charts](https://sponda.capital/en/GSTC/charts.md)
- [Compare](https://sponda.capital/en/GSTC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.